Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129003) titled 'Exploratory Study on Beraprost Sodium Sustained-Release Tablets in Treating Bronchiectasis-Associated Pulmonary Hypertension' on July 29.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Pulmonary Hospital
Condition:
Pulmonary Hypertension Secondary to Bronchiectasis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-17
Target Sample Size: Treatment Group Receiving the Study Drug:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335208
Published by HT Digital Content Services with perm...